Global Pharmaceutical Continuous Manufacturing Market is expected to grow at a CARG of 8.2% during the forecast period 2020-2027
A new research report published by Fior Markets with the title Pharmaceutical Continuous Manufacturing Market by Product (Semi-continuous Systems, Control & Software, Integrated Continuous Systems), Application (API Manufacturing, Final Drug Product Manufacturing), End-User (Contract Manufacturing organization, Pharmaceutical Companies), Distribution channel (Online Pharmacy, Hospital Pharmacy, Retail Pharmacy), global industry analysis, market size, share, growth, trends, and forecast 2019 to 2027.
The global Pharmaceutical Continuous Manufacturing market is expected to grow from USD 2.41 billion in 2019 to USD 4.5 billion by 2027, at a CARG of 8.2% during the forecast period 2020-2027. Europe has the largest share in this market because of high number of pharmaceutical manufacturing companies and the favorable government framework. UK and Germany are the projecting countries contributing for driving the pharmaceutical continuous manufacturing in this region. North America region is the second largest and is predicted to show significant growth in the coming years, due to promising government regulations.
DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/418400/request-sample
The major player of this market are, GEA group AG, Hosokawa Micron Corporation, L.B. Bohle Maschinen, Thermo Fisher Scientific Inc., Glatt GmbH, Coperion GmbH, Bosch Packaging Technology, Korsch AG.
Thermo Fisher Scientific Inc. is investing strategically, to align capacity and capabilities around three areas of greatest demand which are, cell, gene therapy and biologics, and drug product development and commercial capabilities.
The Product segment includes Semi-continuous systems, control & software, Integrated continuous system. The application segment includes API Manufacturing, final drug product manufacturing. Final drug product manufacturing being the highest revenue generator. The end-user segment includes, contract manufacturing organization, pharmaceutical companies. The pharmaceutical companies are expected to contribute the largest share of the pharmaceutical continuous manufacturing.
The distribution channel includes, online pharmacy, hospital pharmacy, retail pharmacy. The retail segment is predicted to have a major share during the forecast year and the online pharmacy is expected to grow at the highest CARG, with increase in preferences for e-commerce platforms and also due to the benefits provided by the online pharmacies like discounts and home delivery.
The rise in government support for CM adoption and increase in implementation of pharmaceutical CM systems rises the growth of this market globally. Still, the high cost of this system hinders the growth of pharmaceuticals continuous manufacturing market. Also, poor demand from the underdeveloped countries hampers the market growth.
About the report:
The global Pharmaceutical Continuous Manufacturing market is analyzed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on firstname.lastname@example.org or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
- CDN Newswire